Quipt Home Medical (TSE:QIPT) Given New C$7.50 Price Target at Stifel Nicolaus

Quipt Home Medical (TSE:QIPTFree Report) had its target price cut by Stifel Nicolaus from C$8.40 to C$7.50 in a research report sent to investors on Thursday morning,BayStreet.CA reports. They currently have a buy rating on the stock.

Quipt Home Medical Price Performance

QIPT opened at C$3.56 on Thursday. The company has a market capitalization of C$153.40 million, a PE ratio of -20.94 and a beta of 1.01. The business has a 50-day moving average of C$3.72 and a 200-day moving average of C$4.11. Quipt Home Medical has a fifty-two week low of C$3.28 and a fifty-two week high of C$6.98.

About Quipt Home Medical

(Get Free Report)

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.

Featured Stories

Receive News & Ratings for Quipt Home Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quipt Home Medical and related companies with MarketBeat.com's FREE daily email newsletter.